Clinical Trial Update: A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a three-day course of azithromycin plus chloroquine for uncomplicated Plasmodium falciparum malaria; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Falciparum Malaria

Drugs mentioned

• Azithromycin (azithromycin)
• Chloroquine (chloroquine)

Snippet

Sponsor: Pfizer | Conditions: Falciparum Malaria | Phase 2 | Status: COMPLETED | Results posted: 2014-06-26